206 related articles for article (PubMed ID: 22595827)
1. A woman with recurrent calcium phosphate kidney stones.
Goldfarb DS
Clin J Am Soc Nephrol; 2012 Jul; 7(7):1172-8. PubMed ID: 22595827
[TBL] [Abstract][Full Text] [Related]
2. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
Hess B
Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
[TBL] [Abstract][Full Text] [Related]
3. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
[TBL] [Abstract][Full Text] [Related]
4. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
5. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR
J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
[TBL] [Abstract][Full Text] [Related]
6. Calcium phosphate stone morphology can reliably predict distal renal tubular acidosis.
Dessombz A; Letavernier E; Haymann JP; Bazin D; Daudon M
J Urol; 2015 May; 193(5):1564-9. PubMed ID: 25498572
[TBL] [Abstract][Full Text] [Related]
7. [Citrate and renal stones].
del Valle EE; Spivacow FR; Negri AL
Medicina (B Aires); 2013; 73(4):363-8. PubMed ID: 23924538
[TBL] [Abstract][Full Text] [Related]
8. Alkaline citrate in prevention of recurrent calcium oxalate stones.
Berg C
Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
[TBL] [Abstract][Full Text] [Related]
9. [Functional evaluation in patients with kidney calculi].
Stojimirović B
Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
[TBL] [Abstract][Full Text] [Related]
10. Divergence between stone composition and urine supersaturation: clinical and laboratory implications.
Lingeman J; Kahnoski R; Mardis H; Goldfarb DS; Grasso M; Lacy S; Scheinman SJ; Asplin JR; Parks JH; Coe FL
J Urol; 1999 Apr; 161(4):1077-81. PubMed ID: 10081841
[TBL] [Abstract][Full Text] [Related]
11. [Carbonic anhydrase inhibitors and calcium phosphate stones].
Barbey F; Nseir G; Ferrier C; Burnier M; Daudon M
Nephrologie; 2004; 25(5):169-72. PubMed ID: 15455790
[TBL] [Abstract][Full Text] [Related]
12. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
13. Urine citrate and renal stone disease.
Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
[TBL] [Abstract][Full Text] [Related]
14. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
15. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of phosphate in calcium oxalate renal stones.
Ohman S; Larsson L; Tiselius HG
Ann Clin Biochem; 1992 Jan; 29 ( Pt 1)():59-63. PubMed ID: 1536527
[TBL] [Abstract][Full Text] [Related]
17. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
[TBL] [Abstract][Full Text] [Related]
18. Prevention of recurrent nephrolithiasis.
Goldfarb DS; Coe FL
Am Fam Physician; 1999 Nov; 60(8):2269-76. PubMed ID: 10593318
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of factors involved in calcium stone formation.
Abraham PA; Smith CL
Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
[TBL] [Abstract][Full Text] [Related]
20. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
